Human NSCLC A549 and H1975 cells, either grown in standard conditions or exposed to TGFβ treatment, were detached from the substrate using Accutase® to minimize the exposure of the extracellular membrane proteins to the enzymatic activity of trypsin. The gene discussed is TGFB1; the disease is non-small cell lung carcinoma.